NewsNational News

Actions

FDA says single-dose shot from J&J prevents severe COVID

Johnson & Johnson COVID-19 Vaccine
Posted
and last updated

ASSOCIATED PRESS — WASHINGTON (AP) — An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days. If the FDA clears the J&J shot for U.S. use, it won’t boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Monday

01/13/2025

Clear

-° / 36°

0%

Tuesday

01/14/2025

Clear

64° / 37°

0%

Wednesday

01/15/2025

Clear

68° / 37°

0%

Thursday

01/16/2025

Clear

67° / 39°

0%

Friday

01/17/2025

Clear

65° / 38°

3%

Saturday

01/18/2025

Mostly Clear

61° / 38°

17%

Sunday

01/19/2025

Clear

59° / 34°

6%

Monday

01/20/2025

Mostly Clear

58° / 33°

1%